Palliation of Dyspnea With Mouth Piece Ventilation

Tampere University Hospital22 enrolled

Overview

An uncontrolled feasibility study on using mouth piece ventilation in palliation of dyspnea in subjects with incurable advanced disease. Subjects are recruited from a local Hospice and from oncology ward. The main outcomes are the compliance of the subjects with the treatment and alleviation of dyspnea during the treatment period.

Study Type

INTERVENTIONAL

Allocation

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Dyspnea

Interventions

Trilogy 100 ® (Philips Respironics)DEVICE

Trilogy 100 ® (Philips Respironics) on MPV mode.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * at least moderate dyspnea (NRS = Numeric Rating Scale ≥ 4) * incurable advanced disease * able to understand the study and to give informed consent * would not gain from intensive care or resuscitation according to the treating physician Exclusion Criteria: * unable to participate and use MPV due to e.g. delirium or lack of co-operation * the cause of the dyspnea can be succesfully treated * unable to give informed consent

Locations (2)

Dpt of oncology, Tampere University Hospital

Tampere, Finland

Pirkanmaa Hospice

Tampere, Finland

Outcomes

Primary Outcomes

Change in dyspnea after initial use of MPV

Time frame: 5 - 60 min

Secondary Outcomes

Change in dyspnea after 24 hours of using MPV

Time frame: 24 hours

Proportion of subjects having side-effects or not being compliant with MPV

Time frame: 24 hours

Proportion of subjects gaining from MPV

Time frame: 24 hours

Proportion of subjects willing to continue on MPV after the intervention

Time frame: 24 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.